May 2025

FDA sees promise in new total artificial heart technology, granting it ‘breakthrough’ status ()
New-look peripheral stent with expandable spikes receives FDA’s de novo classification ()
The lack of diversity in cardiac surgery trials may be harmful to patients ()
SCAI celebrates legacies of pioneer pediatric cardiologists ()
Private equity's influence continues to rise in cardiology—what does that mean for patient care? ()
Terumo Interventional Systems launches dual-layer micromesh carotid stent after FDA approval ()
How anticoagulants may impact a patient’s risk of gastrointestinal bleeding after TAVR ()
Marijuana use linked to blood vessel damage—impact seen with smoking and edibles ()
Cuffless blood pressure measurement devices: Convenient, but not ready for clinical use ()
Veteran surgeon unpacks major changes in the world of cardiac surgery ()
Boston Scientific pulls plug on TAVR devices after failing to gain FDA approval ()
The average wait time to see a cardiologist is now more than a month ()
FDA approves self-expanding Tendyne TMVR device from Abbott ()
Permanent pacemaker implantation after mitral valve surgery: Exploring the impact on long-term survival ()
Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards ()
Medtronic drug-coated balloon gains multiple new approvals ()
SCAI wants lead-free cath labs and a better work-life balance for cardiologists ()
Cardiologist shares positive first-in-human data on TriCares TTVR device ()
FDA wants new heart damage warnings added to COVID-19 vaccines ()
Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs ()
Work begins on first ATTR-CM study of its kind ()
Cardiologists make history, use new robotic imaging system for first time ()
Medtronic to spin off its diabetes business ()
LVOT modification during robotic mitral valve repair limits complications ()
Stroke care continues to evolve thanks to AI, cardiologists and more ()
Johnson & Johnson MedTech launches new 2D ICE catheter ()
Medtronic gains a key approval for Evolut TAVR valves ()
Chest tube-clearing device improves recovery, limits readmissions after heart surgery ()
IVL delivers significant value for women, real-world data confirm ()
Same-day discharge after TAVR linked to positive outcomes ()
Johnson & Johnson MedTech ordered to pay $147M for antitrust violations ()
2 out of 5 heart failure patients are not seeing a cardiologist ()
Heart patients, stroke survivors may live longer if they stay active after hospital discharge ()
Robotic PCI confirmed to be both safe and effective in new comprehensive analysis ()
Cardiology employment models undergoing a dramatic shift ()
AI delivers real-time blood clot monitoring, helping cardiologists make treatment decisions ()
Original Banksy artwork headed to auction—proceeds will help fund heart research ()
Duke specialists to detail the benefits of treating heart failure with Barostim ()
Intra-annular TAVR valves from Edwards Lifesciences and Abbott deliver similar 1-year outcomes ()
TAVR for Today’s Patient: Updates on Data, Risk, Anatomy, and Access ()
Imaging for chest pain: CT- and ICA-first strategies linked to similar long-term health status ()
Abbott's FreeStyle Libre helps patients with diabetes stay out of the hospital ()
Semaglutide works fast, protecting the heart before weight loss kicks in ()
It may not be easy, but it changes lives: Reframing myths of healthcare leadership ()
PCI just as successful when patients have a history of TAVR—but there are some added risks ()
Cardiology groups among the many voices asking Congress not to cut Medicaid ()
FDA approves popular ultrasound enhancing agent for pediatric patients ()
Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve ()
FDA gives AI-powered blood test for obstructive CAD breakthrough device designation ()
New drug for obstructive HCM outperforms the current standard of care ()
GE HealthCare debuts new wide-bore MRI scanner built with cardiology, oncology in mind ()
When valves fail: Surgeons share advice for treating high-risk patients with TAVR explant and SAVR ()
ASNC, ACC ask US government not to tariff radiopharmaceuticals ()
Gastric bypass surgery linked to lower heart attack risk than gastric sleeve ()
Obicetrapib linked to substantial reductions in LDL cholesterol for high-risk heart patients ()
TAVR and SAVR deliver similar outcomes for patients with low-flow, low-gradient aortic stenosis ()
A new use for IVL: helping cardiologists secure transcarotid access for TAVR ()
Cardiologists are first in world to use new cooling device to terminate AFib during surgery ()
CCTA shows colchicine's impact on atherosclerosis progression ()
Rates of obesity, high blood pressure and diabetes keep climbing in US ()
AI-enabled CCTA evaluations reduce use of invasive imaging exams ()
High Lp(a) levels increase risk of repeat cardiovascular events—LDL drugs may help ()
Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients ()
Stenting ‘an important treatment option’ for PCI patients with complete blockages ()
Smaller LV dimensions may increase risk of death for HeartMate 3 LVAD patients ()
World’s first leadless LBBAP procedures linked to ‘promising’ outcomes ()
Tirzepatide bests semaglutide in patients with type 2 diabetes, kidney disease and heart failure ()
AI predicts LBBB risk in TAVR patients prior to treatment ()
New SCAI president lists advocacy, cardiogenic shock among his top priorities ()
Consistent cannabis use linked to multiple cardiovascular risks for heart failure patients ()
A super alternative: BATMAN helps cardiologists limit complications during TMVR ()
‘A defining moment’: How cardiologists can get the most out of CT-guided PCI ()
Nonprofit group helps doctors and startups bring new cardiovascular tech to market ()
FDA approves new AI-enabled wearable cardioverter defibrillator ()
Cardiologists share late-breaking TAVR data on first day of SCAI 2025 ()
Latest EARLY TAVR data suggest it is time to update industry guidelines ()
A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis ()